A case-control study of infections caused by Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase-1: Predictors and outcomes
- PMID: 35967868
- PMCID: PMC9366880
- DOI: 10.3389/fcimb.2022.867347
A case-control study of infections caused by Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase-1: Predictors and outcomes
Abstract
Introduction: Infections caused by antimicrobial-resistant bacteria are a significant cause of death worldwide, and carbapenemase-producing bacteria are the principal agents. New Delhi metallo-beta-lactamase-1 producing Klebsiella pneumoniae (KP-NDM-1) is an extensively drug-resistant bacterium that has been previously reported in Mexico. Our aim was to conduct a case-control study to describe the risk factors associated with nosocomial infections caused by K. pneumoniae producing NDM-1 in a tertiary-care hospital in Mexico.
Methods: A retrospective case-control study with patients hospitalized from January 2012 to February 2018 at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" was designed. During this period, 139 patients with a culture that was positive for K. pneumoniae NDM-1 (cases) and 486 patients hospitalized in the same department and on the same date as the cases (controls) were included. Data were analyzed using SPSS v. 24, and logistic regression analysis was conducted to calculate the risk factors for KP-NDM-1 infection.
Results: One hundred and thirty-nine case patients with a KP-NDM-1 isolate and 486 control patients were analyzed. In the case group, acute renal failure was a significant comorbidity, hospitalization days were extended, and significantly more deaths occurred. In a multivariate analysis of risk factors, the independent variables included the previous use of antibiotics (odds ratio, OR = 12.252), the use of a urinary catheter (OR = 5.985), the use of a central venous catheter (OR = 5.518), the use of mechanical ventilation (OR = 3.459), and the length of intensive care unit (ICU) stay (OR = 2.334) as predictors of infection with NDM-1 K. pneumoniae.
Conclusion: In this study, the previous use of antibiotics, the use of a urinary catheter, the use of a central venous catheter, the use of mechanical ventilation, and ICU stay were shown to be predictors of infection with NDM-1 K. pneumoniae and were independent risk factors for infection with NDM-1 K. pneumoniae.
Keywords: Klebsiella pneumoniae; NDM-1; bacterial resistance; carbapenemases; healthcare-associated infections; metallo-beta-lactamases; resistance mechanisms.
Copyright © 2022 Rodríguez-Noriega, Garza-González, Bocanegra-Ibarias, Paz-Velarde, Esparza-Ahumada, González-Díaz, Pérez-Gómez, Escobedo-Sánchez, León-Garnica and Morfín-Otero.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Infection with the multidrug-resistant Klebsiella pneumoniae New Delhi metallo-B-lactamase strain in patients with COVID-19: Nec Hercules contra plures?.Front Cell Infect Microbiol. 2024 Apr 16;14:1297312. doi: 10.3389/fcimb.2024.1297312. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38690325 Free PMC article.
-
Isolation of the first New Delhi metallo-ß-lactamase-1 (NDM-1)-producing and colistin-resistant Klebsiella pneumoniae sequence type ST15 from a digestive carrier in Albania, May 2018.J Glob Antimicrob Resist. 2019 Jun;17:142-144. doi: 10.1016/j.jgar.2018.12.002. Epub 2018 Dec 14. J Glob Antimicrob Resist. 2019. PMID: 30557684
-
Risk factors and epidemiologic predictors of blood stream infections with New Delhi Metallo-b-lactamase (NDM-1) producing Enterobacteriaceae.Epidemiol Infect. 2019 Jan;147:e137. doi: 10.1017/S0950268819000256. Epidemiol Infect. 2019. PMID: 30869056 Free PMC article.
-
Current status of NDM-producing Enterobacterales in Brazil: a narrative review.Braz J Microbiol. 2022 Sep;53(3):1339-1344. doi: 10.1007/s42770-022-00779-1. Epub 2022 Jun 11. Braz J Microbiol. 2022. PMID: 35690653 Free PMC article. Review.
-
Panorama of Bacterial Infections Caused by Epidemic Resistant Strains.Curr Microbiol. 2022 Apr 30;79(6):175. doi: 10.1007/s00284-022-02875-9. Curr Microbiol. 2022. PMID: 35488983 Free PMC article. Review.
Cited by
-
Ceftazidime-Decorated Gold Nanoparticles: a Promising Strategy against Clinical Ceftazidime-Avibactam-Resistant Enterobacteriaceae with Different Resistance Mechanisms.Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0026223. doi: 10.1128/aac.00262-23. Epub 2023 Jun 26. Antimicrob Agents Chemother. 2023. PMID: 37358468 Free PMC article.
-
Molecular Epidemiology of Carbapenem-Resistant K. pneumoniae Clinical Isolates from the Adult Patients with Comorbidities in a Tertiary Hospital, Southern Saudi Arabia.Antibiotics (Basel). 2022 Nov 25;11(12):1697. doi: 10.3390/antibiotics11121697. Antibiotics (Basel). 2022. PMID: 36551354 Free PMC article.
-
Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations?Infect Dis Ther. 2024 Nov;13(11):2423-2447. doi: 10.1007/s40121-024-01044-8. Epub 2024 Oct 1. Infect Dis Ther. 2024. PMID: 39352652 Free PMC article. Review.
-
Gold Nanoparticles Functionalized With 5-Amino-2-Mercaptobenzimidazole: A Promising Antimicrobial Strategy Against Carbapenem-Resistant Gram-Negative Bacteria.Int J Nanomedicine. 2025 Feb 27;20:2485-2504. doi: 10.2147/IJN.S502139. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40034218 Free PMC article.
References
-
- Alcantar-Curiel M. D., Fernandez-Vazquez J. L., Toledano-Tableros J. E., Gayosso-Vazquez C., Jarillo-Quijada M. D., Lopez-Alvarez M. D. R., et al. . (2019). Emergence of IncFIA plasmid-carrying blaNDM-1 among klebsiella pneumoniae and enterobacter cloacae isolates in a tertiary referral hospital in Mexico. Microb. Drug Resist. 25 (6), 830–838. doi: 10.1089/mdr.2018.0306 - DOI - PubMed
-
- Amarsy R., Jacquier H., Munier A. L., Merimeche M., Bercot B., Megarbane B. (2021). Outbreak of NDM-1-producing klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: Another nightmare. Am. J. Infect. Control 49 (10), 1324–1326. doi: 10.1016/j.ajic.2021.07.004 - DOI - PMC - PubMed
-
- Aung A. H., Kanagasabai K., Koh J., Hon P. Y., Ang B., Lye D., et al. . (2021). Epidemiology and transmission of carbapenemase-producing enterobacteriaceae in a health care network of an acute-care hospital and its affiliated intermediate- and long-term-care facilities in Singapore. Antimicrob. Agents Chemother. 65 (8), e0258420. doi: 10.1128/AAC.02584-20 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources